Irradiation enhances mammalian target of rapamycin (mTOR)-targeted glioblastoma therapy with CCI-779 (temsirolimus)

被引：0

作者：

Weiler, M. ^{[1
,2
]}

Pfenning, P-N ^{[1
]}

Thiepold, A-L ^{[1
]}

Jestaedt, L. ^{[2
]}

Berger, B. ^{[1
,2
]}

Combs, S. ^{[2
]}

Bendszus, M. ^{[2
]}

Wick, W. ^{[1
,2
]}

机构：

[1] German Canc Res Ctr, Clin Cooperat Unit, D-6900 Heidelberg, Germany

[2] Univ Heidelberg Hosp, Heidelberg, Germany

来源：

ONKOLOGIE | 2010年 / 33卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：60 / 60

页数：1

共 50 条

[31] The mTOR inhibitor temsirolimus (CCI-779) induces cell cycle arrest and autophagy in Hodgkin lymphoma (HL) cell lines and enhances the effect of the p13-kinase inhibitor LY294002. [J].

Georgakis, Georgios V. ;

Yazbeck, Victor Y. ;

Li, Yang ;

Younes, Anas .

BLOOD, 2006, 108 (11) :639A-639A

[32] Molecular mechanisms of the mTOR inhibitor temsirolimus (CCI-779) antiproliferative effects in mantle cell lymphoma: Induction of cell cycle arrest, autophagy, and synergy with vorinostat (SAHA). [J].

Yazbeek, Victor Y. ;

Georgakis, Georgios V. ;

Li, Yang ;

Iwado, Eiji ;

Kondo, Seiji ;

Younes, Anas .

BLOOD, 2006, 108 (11) :706A-706A

[33] Combination of Temsirolimus (CCI-779) with Chemoradiation in Newly Diagnosed Glioblastoma Multiforme (GBM) (NCCTG trial N027D) Is Associated with Increased Infectious Risks [J].

Sarkaria, Jann N. ;

Galanis, Eva ;

Wu, Wenting ;

Dietz, Allan B. ;

Kaufmann, Timothy J. ;

Gustafson, Michael P. ;

Brown, Paul D. ;

Uhm, Joon H. ;

Rao, Ravi D. ;

Doyle, Laurence ;

Giannini, Caterina ;

Jaeckle, Kurt A. ;

Buckner, Jan C. .

CLINICAL CANCER RESEARCH, 2010, 16 (22) :5573-5580

[34] Mammalian target of rapamycin (mTOR) signaling pathway and traumatic brain injury: A novel insight into targeted therapy [J].

Movahedpour, Ahmad ;

Vakili, Omid ;

Khalifeh, Masoomeh ;

Mousavi, Pegah ;

Mahmoodzadeh, Amir ;

Taheri-Anganeh, Mortaza ;

Razmeh, Saeed ;

Shabaninejad, Zahra ;

Yousefi, Fatemeh ;

Behrouj, Hamid ;

Ghasemi, Hassan ;

Khatami, Seyyed Hossein .

CELL BIOCHEMISTRY AND FUNCTION, 2022, 40 (03) :232-247

[35] Inhibition of mammalian target of rapamycin (mTOR) signaling by Temsirolimus as a potential therapeutic strategy for esophageal cancer treatment [J].

Takaoka, Munenori ;

Nishikawa, Toshio ;

Ohara, Toshiaki ;

Tomono, Yasuko ;

Fujiwara, Yasuhiro ;

Shirakawa, Yasuhiro ;

Nagatsuka, Hitoshi ;

Fukazawa, Takuya ;

Yamatsuji, Tomoki ;

Bao, Xiaohong ;

Hao, Huifang ;

Shigemitsu, Kaori ;

Morita, Ichiro ;

Fujiwara, Toshiyoshi ;

Naomoto, Yoshio .

CANCER RESEARCH, 2011, 71

[36] Effect of combined therapy with temsirolimus (CCI-779), temozolomide (TMZ), and radiation (RT) in newly diagnosed glioblastoma multiforme (GBM) patients on immune suppression: Results from NCCTG N027D [J].

Sarkaria, J. N. ;

Galanis, E. ;

Gustafson, M. P. ;

Dietz, A. B. ;

Wu, W. ;

Brown, P. D. ;

Uhm, J. H. ;

Giannini, C. ;

Jaeckle, K. A. ;

Buckner, J. C. .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)

[37] GEMCITABINE COMBINED WITH THE MTOR INHIBITOR TEMSIROLIMUS(CCI-779) IN PATIENTS WITH INOPERABLE OR METASTATIC PANCREATIC CANCER (HE 3/07). A PHASE I STUDY BY THE HELLENIC COOPERATIVE ONCOLOGY GROUP [J].

Karavasilis, V. ;

Pentheroudakis, G. ;

Sgouros, J. ;

Dimoudis, S. T. ;

Varthalitis, I. ;

Samantas, E. ;

Fountzilas, G. .

ANNALS OF ONCOLOGY, 2012, 23 :239-239

[38] Innovations therapy: mammalian target of rapamycin (mTOR) inhibitors for the treatment of neuroendocrine tumors [J].

Capdevila, Jaume ;

Salazar, Ramon ;

Halperin, Irene ;

Abad, Albert ;

Yao, James C. .

CANCER AND METASTASIS REVIEWS, 2011, 30 (01) :27-34

[39] Innovations therapy: mammalian target of rapamycin (mTOR) inhibitors for the treatment of neuroendocrine tumors [J].

Jaume Capdevila ;

Ramón Salazar ;

Irene Halperín ;

Albert Abad ;

James C. Yao .

Cancer and Metastasis Reviews, 2011, 30 :27-34

[40] Mammalian Target of Rapamycin (mTOR) Inhibition: Potential for Antiseizure, Antiepileptogenic, and Epileptostatic Therapy [J].

Ryther, Robin C. C. ;

Wong, Michael .

CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2012, 12 (04) :410-418

← 1 2 3 4 5 →